REN and cancer: There is some evidence to suggest that concomitant treatment with antihypertensive agents targeting the renin‐angiotensin‐aldosterone system, or calcium signaling pathways, may improve progression‐free survival and overall survival in cancer patients (reviewed by reference.34 Moreover, in vitro data suggest that nitrates and beta‐blockers may also be associated with cancer regression.